Genetic variants at the SORT1 locus in humans, which cause increased SORT1 expression in the liver, are significantly associated with reduced plasma levels of LDL cholesterol and apolipoprotein B (apoB). However, the role of hepatic sortilin remains controversial, as genetic deletion of sortilin in mice has resulted in variable and conflicting effects on apoB secretion. Here, we found that Sort1-KO mice on a chow diet and several Sort1-deficient hepatocyte lines displayed no difference in apoB secretion. When these models were challenged with high-fat diet or ER stress, the loss of Sort1 expression resulted in a significant increase in apoB-100 secretion. Sort1-overexpression studies yielded reciprocal results. Importantly, carriers of SORT1 variant with diabetes had larger decreases in plasma apoB, TG, and VLDL and LDL particle number as compared with people without diabetes with the same variants. We conclude that, under basal nonstressed conditions, loss of sortilin has little effect on hepatocyte apoB secretion, whereas, in the setting of lipid loading or ER stress, sortilin deficiency leads to increased apoB secretion. These results are consistent with the directionality of effect in human genetics studies and suggest that, under stress conditions, hepatic sortilin directs apoB toward lysosomal degradation rather than secretion, potentially serving as a quality control step in the apoB secretion pathway in hepatocytes.
Donna M. Conlon, Carolin V. Schneider, Yi-An Ko, Amrith Rodrigues, Kathy Guo, Nicholas J. Hand, Daniel J. Rader
Title and authors | Publication | Year |
---|---|---|
Sortilin and its potential role in cardiovascular pathology
Namitokov A |
The Egyptian Heart Journal | 2024 |
VLDL Biogenesis and Secretion: It Takes a Village.
van Zwol W, van de Sluis B, Ginsberg HN, Kuivenhoven JA |
Circulation research | 2024 |
Molecular Regulation and Therapeutic Targeting of VLDL Production in Cardiometabolic Disease
Burks KH, Stitziel NO, Davidson NO |
Cellular and Molecular Gastroenterology and Hepatology | 2024 |
Impaired chaperone-mediated autophagy leads to abnormal SORT1 (sortilin 1) turnover and CES1-dependent triglyceride hydrolysis
Choi YJ, Nam YA, Hyun JY, Yu J, Mun Y, Yun SH, Lee W, Park CJ, Han BW, Lee BH |
Autophagy | 2024 |
A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B.
Liu JT, Doueiry C, Jiang YL, Blaszkiewicz J, Lamprecht MP, Heslop JA, Peterson YK, Carten JD, Traktman P, Yuan Y, Khetani SR, Twal WO, Duncan SA |
Communications biology | 2023 |
Sorting through the extensive and confusing roles of sortilin in metabolic disease
Mitok KA, Keller MP, Attie AD |
Journal of lipid research | 2022 |
Endosomal trafficking in metabolic homeostasis and diseases.
Gilleron J, Zeigerer A |
Nature reviews. Endocrinology | 2022 |
Sortilin and hypertension
Avvisato R, Jankauskas SS, Varzideh F, Kansakar U, Mone P, Santulli G |
Current Opinion in Nephrology and Hypertension | 2022 |